Metropolitan Urology

Jeffersonville, Indiana 47130

0 studies enrolling now · 11 studies all time

What they study most

Benign Prostatic Hyperplasia, Bladder Cancer, Bladder Cancer Recurrence, Cystitis, Interstitial, Fractures, Microscopic or Gross Hematuria, Osteoporosis, Overactive Bladder, Prostate Cancer, Urinary Incontinence

Studies at this site

• A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
• An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
• PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy — Completed
• MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence. — Completed
• Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer — Completed
• Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer — Completed
• Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia — Stopped early
• Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder — Completed